NLRP3 and arthritic joint disease: For example, miR-223 has been shown to target the NLRP3 inflammasome in the brain and reduce neuroinflammation and neuronal damage [185], inhibit NLRP3 expression, and reduce inflammation in various disease models, including arthritis, atherosclerosis, and myocardial infarction [56,186,187].